1968 List of Prohibited Classes of Substances and Prohibited Methods / IOC Medical Commission. – Lausanne : International Olympic Committee (IOC), 1968. – (Newsletter (1968) 5 (Février-February) ; p. 47, 71-73)
Under the chairmanship of Prince Alexandre de Mérode, the IOC Medical Commission has on one hand carried out its work in Grenoble and on the other hand brought about certain changes in the rules concerning the doping and sex tests.
The IOC Medical Commission is composed of the following members:
- Prince Alexandre de Mérode - Chairman (IOC)
- Mr. A. Csanadi, Vice - Chairman (IOC)
- Dr. A. Dirix (Belgium)
- Prof. L. Prokop (Austria)
- Prof. C. La Cava (Italy)
- Prof. A. Beckett (Great Britain)
- Dr. P. van Dijk (Netherlands)
- Dr. E. Hay (Mexico)
- Dr. Thiébault (Org. Com. of Xth Olympic Winter Games)
These are the modifications made to the tests which up to now have been in force.
1) Modifications of the sanctions (I.O.C. Rules and Regulations p.46 "Doping") are as follows:
Exclusion from the Olympic Games
- The athlete who, in an individual sport, has been shown to have used dope is excluded from the Olympic Games.
- In team sport: the team of an athlete who has been shown to have used dope is excluded, if the team can benefit from this usage.
In those sports (gymnastics, modern pentathlon) where the team can no longer participate because of the disqualification of one athlete, the remainder of the team will be able to take part on an individual basis.
- The athlete who does not attend for the control will be disqualified.
2) The control will be carried out according to the most modern and appropriate methods and at the discretion of the Medical Commission in consultation with the I.F.S. concerned.
3) The list of products has been definitively fixed for the Grenoble Games as follows:
A.) Sympathomimetic Amines (e.g. amphetamine), ephedrine and similar substances,
B.) Stimulants of the central nervous system (strychnine) and analeptics,
C.) Narcotics and analgesics (e.g. morphine), similar substances ,
D.) Anti-depressants (e.g. IMAO), imipramine and similar substances,
E.) Major tranquillisers (e.g. Phenothiazine).
Information selected from the original document:
Lettre d’information Newsletter (1968) 5 (Février / February) ; p. 47-80)
Source: Bibliothèque du CIO / IOC Library